spacer
home > pmps > autumn 2019 > lost in translation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Lost in Translation




From a regulatory perspective, working primarily with chemical industrial and retail products, there are several translation challenges businesses face when looking to market their products. During the process of creating a product label, questions concerning label translations will arise: what language is required? Are there exemptions for this product? Will the necessary information fit on the label? How can the quality of the translation be ensured?

The answers to these questions depend on the country-specific regulations, the required label content, and the methods of obtaining a translation. It is important to remember that there are many entities that rely on the content of a product label. These include regulatory enforcement agencies (customs), international shipping companies, manufacturers, suppliers, distributors, and the end user (retail or workplace). Each organisation has different responsibilities regarding the product labelling. Manufacturers, suppliers, and distributors are typically responsible for the generation of compliant labels. The Globally Harmonized System (GHS) of Classification and Labelling of Chemicals can apply to retail and the workplace, which could also include pharmaceutical inputs, i.e., excipients.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Alison Senyi is a Regulatory Consultant at Nexreg Compliance, assisting with various SDS, labelling, and consulting projects. Alison finds the challenges of her regulatory role rewarding and enjoys taking an active role in bringing on new services to meet the everchanging compliance needs of the industry. Prior to joining Nexreg in 2016, she completed a Bachelorís degree at the University of Ottawa, Canada, and a Certificate of Occupational Safety and Health from Algonquin College, Canada. Alisonís background in health and safety has given her a greater understanding of the hazards of chemical products, which motivates her to promote awareness about chemical safety and compliance.


Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm Expands Relationship With Novan On Formulation Science

MedPharm Ltd, a leader in topical and transdermal drug delivery, has expanded its relationship with the NASDAQ listed biopharmaceutical company Novan Inc. MedPharm has previously supported Novan by testing the companyís unique formulations using its proprietary in vitro models to optimise Novanís formulations and de-risk product development.
More info >>

White Papers

Pharmacovigilance and Risk Management Information in Centralised Applications in the EU

United BioSource Corporation (UBC)

Getting a new medication approved for the EU market through the centralised procedure can be complex and needs expertise. The new EU pharmacovigilance legislation (Good Vigilance Practice, GVP) is now in effect and applicants need to be fully compliant. It is critical to have a thorough understanding of the regulatory process and requirements, and the expectations with regards to the pharmacovigilance system and the risk management plan. Ensuring consistency and an appropriate level of detail in the documentation submitted as part of the approval process will help prevent unnecessary delays.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement